Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of Presentations at the 20...
November 30 2018 - 9:00AM
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage
biopharmaceutical company, today announced that it will host a
conference call and live audio webcast on Monday, December 3, 2018
at 9:00 am Eastern Time (6:00 am Pacific Time) to provide a
corporate update and overview of the Company’s poster presentations
on two clinical stage epilepsy products, XEN1101 and XEN901, at the
2018 American Epilepsy Society (AES) Meeting.
Dial-In & Webcast
InformationTo participate in the call, please
dial (855) 779-9075, or (631) 485-4866 for international callers,
and provide conference ID number 5369265. The webcast will be
broadcast live on the “Investors” section of Xenon's website
at www.xenon-pharma.com and will be available for replay
following the call for 30 days.
About Xenon Pharmaceuticals
Inc.
We are a clinical stage, neurology-focused
biopharmaceutical company focused on developing innovative
therapeutics to improve the lives of patients with neurological
disorders. Building upon our extensive knowledge of human genetics
and diseases caused by mutations in ion channels, known as
channelopathies, we are advancing – both independently and with our
collaborators – a novel product pipeline of central nervous system,
or CNS, therapies to address areas of high unmet medical need, such
as epilepsy, migraine and pain. For more information, please visit
www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered
trademarks or trademarks of Xenon Pharmaceuticals Inc. in various
jurisdictions. All other trademarks belong to their respective
owner.
Investor/Media Contact:Jodi
Regts Xenon Pharmaceuticals Inc. Phone: 604.484.3353 Email:
investors@xenon-pharma.com
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Sep 2023 to Sep 2024